Finally, silencing of FoxM1 expression could inhibit human hepatocellular carcinoma growth [30], and FoxM1 has been reported an underlying therapeutic target because it can be presented to cell surface by tumor cells [31]. Here, FOXM1 is linked to hepatocellular carcinoma.